Guoyun Bai

Johnson & Johnson (United States)

Papers

1

Total Citations

6

H-Index

1

About

Guoyun Bai is a leading figure in analytical chemistry and drug discovery, specializing in high-throughput separation technologies. His work centers on advancing automated platforms for purification and analysis, particularly through the integration of reversed-phase high-performance liquid chromatography (RP-HPLC), mass spectrometry (MS), and supercritical fluid chromatography (SFC). Bai’s major contribution lies in developing robust, scalable systems that accelerate the identification and purification of drug candidates, addressing critical bottlenecks in pharmaceutical research. His most-cited paper, “Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery” (2024), with 6 citations, exemplifies his impact by detailing a novel approach that combines speed, precision, and automation—key for modern medicinal chemistry. This work has been recognized for its potential to streamline early-stage drug development, reducing time and resource demands. Bai’s achievements underscore his role in bridging analytical innovation and practical drug discovery, making him a valuable resource for students and researchers seeking efficient solutions in chemical analysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery
6 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago